1.58
Macrogenics Inc Borsa (MGNX) Ultime notizie
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates - MSN
MacroGenics appoints Eric Risser as CEO as Scott Koenig exits - The Business Journals
MacroGenics price target lowered to $5 from $8 at Leerink - TipRanks
MacroGenics Price Target Lowered to $5 at Leerink - AInvest
Macrogenics 2025 Q2 Earnings Narrowed Losses and Strong Revenue Growth - AInvest
MacroGenics stock maintains Market Perform rating at Citizens JMP By Investing.com - Investing.com Canada
MacroGenics Inc. Reports Q2 2025 Financial Results - TipRanks
MacroGenics: Q2 Earnings Snapshot - Chron
MacroGenics (MGNX): Strategic Transition, Pipeline Progress, and Liquidity Outlook for Biotech Investors - AInvest
MacroGenics appoints new CEO - MSN
MacroGenics Slows Its Losses And Adds $70 Million To The Bank - Finimize
MacroGenics Revenue Doubles in Q2 - The Globe and Mail
MacroGenics Appoints Eric Risser as New CEO - The Globe and Mail
MacroGenics Inc earnings missed by $0.11, revenue fell short of estimates - Investing.com
MacroGenics Revenue Doubles in Q2 - The Motley Fool
MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities - GlobeNewswire
MacroGenics Reports Q2 2025 Financials, Updates Key Strategic Priorities - AInvest
MacroGenics Extends Cash Runway to 2027 with $70M Royalty Deal as New CEO Unveils Strategic Roadmap - Stock Titan
MacroGenics’ MGC026 Study: A New Hope for Advanced Solid Tumors? - TipRanks
MacroGenics promotes Eric Risser to president and CEO - The Pharma Letter
MacroGenics' Leadership Transition: A Strategic Inflection Point for Capital Efficiency and Growth - AInvest
Short Term Charts Align With Long Term Uptrend in MacroGenics Inc.July 2025 Intraday Action & Weekly Market Pulse Updates - beatles.ru
MacroGenics Appoints Eric Risser As CEO - MarketScreener
MacroGenics names Eric Risser as new CEO, succeeding Scott Koenig By Investing.com - Investing.com Nigeria
MacroGenics Appoints Eric Risser as President and Chief Executiv - GuruFocus
MacroGenics appoints Eric Risser as new CEO, succeeding Scott Koenig By Investing.com - Investing.com Australia
MacroGenics Appoints Eric Risser as President and Chief Executive Officer - GlobeNewswire
MacroGenics Taps Deal-Making Expert Eric Risser as CEO After 24-Year Leadership Run Ends - Stock Titan
How liquid is MacroGenics Inc. stockBreakout Stocks for Quick Return - mustnews.co.kr
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics, Inc. LawsuitMGNX - ACCESS Newswire
What makes MacroGenics Inc. stock price move sharplyFast-track wealth growth - Jammu Links News
What analysts say about MacroGenics Inc. stockUnmatched profit growth - Jammu Links News
How volatile is MacroGenics Inc. stock compared to the marketAccelerate your capital gains today - Jammu Links News
Does MacroGenics Inc. stock perform well during market downturnsInvest smarter with high-probability setups - Jammu Links News
What institutional investors are buying MacroGenics Inc. stockDynamic investment opportunities - Jammu Links News
What are the latest earnings results for MacroGenics Inc.Unbelievable profit margins - Jammu Links News
What are MacroGenics Inc. company’s key revenue driversHigh-yield investments - Jammu Links News
Is MacroGenics Inc. a growth stock or a value stockSuperior return velocity - Jammu Links News
How strong is MacroGenics Inc. company’s balance sheetEntry Signal Growth Plan For Every Investor - Jammu Links News
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics LawsuitMGNX - ACCESS Newswire
MacroGenics’ Prostate Cancer Study: A Potential Game-Changer? - TipRanks
MacroGenics' Prostate Cancer Study: Lorigerlimab's Potential Impact on Treatment Outcomes - AInvest
Why MacroGenics Inc. stock attracts strong analyst attentionTriple Digit Return Stock Predictions Released - metal.it
MacroGenics’ Phase 2 Study: A Potential Game-Changer in Prostate Cancer Treatment? - TipRanks
RSI and MACD Indicate Shift in MacroGenics Inc. SentimentProven Entry Plan With Low Risk Shared - metal.it
Is MacroGenics Inc. Starting a New UptrendBuy Low Sell High Stock Watch Strategy in Focus - metal.it
MacroGenics’ Promising Study on Advanced Solid Tumors: Key Insights for Investors - TipRanks
Will MacroGenics Inc. see short term momentumWeekly Trend Watch with Market Signals - Newser
What the charts say about MacroGenics Inc. todayGrowth Summary Based on Market Positioning - Newser
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):